Skip to main content
. 2022 Mar 16;12(5):1266–1281. doi: 10.1158/2159-8290.CD-21-1136

Figure 4.

Figure 4. Matched targeted treatment recommendations per genetic alterations (only one alteration by gene and those occurring in more than five cases are represented). PD1/PD1Li: programmed cell death protein 1/ligand immune checkpoint inhibitors; GSi: gamma-secretase inhibitor; TMB, tumor mutational burden.

Matched targeted treatment recommendations per genetic alterations (only one alteration by gene and those occurring in more than five cases are represented). GSi, gamma-secretase inhibitor; PD1/PD1Li, programmed cell death protein 1/ligand immune checkpoint inhibitors; TMB, tumor mutational burden.